NLSCX
Price
$17.41
Change
+$0.01 (+0.06%)
Updated
Sep 20 closing price
VLSAX
Price
$18.01
Change
-$0.03 (-0.17%)
Updated
Sep 20 closing price
Ad is loading...

NLSCX vs VLSAX

Header iconNLSCX vs VLSAX Comparison
Open Charts NLSCX vs VLSAXBanner chart's image
Neuberger Berman Long Short C
Price$17.41
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
Virtus KAR Long/Short Equity A
Price$18.01
Change-$0.03 (-0.17%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NLSCX vs VLSAX Comparison Chart
Loading...
VS
NLSCX vs. VLSAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSCX is a Buy and VLSAX is a Sell.

FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.17B vs. VLSAX (62.2M). NLSCX pays higher dividends than VLSAX: NLSCX (0.03) vs VLSAX (0.00). NLSCX was incepted earlier than VLSAX: NLSCX (13 years) vs VLSAX (6 years). NLSCX is a more actively managed with annual turnover of: 54.00 vs. VLSAX (13.00). NLSCX has a lower initial minimum investment than VLSAX: NLSCX (1000) vs VLSAX (2500). VLSAX annual gain was more profitable for investors over the last year : 9.35 vs. NLSCX (8.18). VLSAX return over 5 years is better than : 41.81 vs. NLSCX (19.49).
NLSCXVLSAXNLSCX / VLSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years6 years-
Gain YTD4.5675.13789%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets7.17B62.2M11,534%
Annual Yield % from dividends0.030.00-
Returns for 1 year8.189.3587%
Returns for 3 years1.00-3.74-27%
Returns for 5 years19.4941.8147%
Returns for 10 years28.67N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JWGRX117.13N/A
N/A
Janus Henderson Global Research S
FEAAX44.18-0.01
-0.02%
Fidelity Advisor Emerging Asia A
HGHVX52.02-0.29
-0.55%
Hartford Healthcare R6
RPEBX62.99-0.38
-0.60%
American Funds New Perspective R2E
ABIYX16.37-0.15
-0.91%
AB International Value Advisor